Monday, August 31, 2026
ExploreSearch
Via News
Markets

Two Hours Before The NYSE Open, Novartis AG Is Up By 2%

ViaNews Editorial Team

December 28, 2020

Two Hours Before The NYSE Open, Novartis AG Is Up By 2%

NYSE Composite opens in less than two hours and Novartis AG's premarket value is already 2.47% up.

The last session, nYSE Composite ended with Novartis AG rising 0.19% to $88.55. NYSE Composite slid 0.11% to $14,382.50, following last session's downward trend on what was a somewhat negative trend exchanging session.

Novartis AG's last close was $88.38, 12.75% below its 52-week high of $99.84.

Novartis AG's Sales

Novartis AG's sales growth is 3.9% for the present quarter and 6.3% for the next. The company's growth estimates for the current quarter and the next is 2.3% and 1.3%, respectively.

Categories

Markets

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNYSEMarket SessionNYAThe New York Stock ExchangeStock Price UpNovartis AGNVSPremarket
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com